Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 38345-66-3
2. D-oxyphene
3. (2s,3r)-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol
4. (+)-darvon Alcohol
5. (2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-ol
6. Oxyphene
7. 5917uss6pv
8. Darvon Alcohol
9. Mosher's Reagent
10. (+)-oxyphene
11. Unii-5917uss6pv
12. (2s,3r)-4-(dimethylamino)-1,2-diphenyl-3-methylbutan-2-ol (oxyphene)
13. Einecs 253-893-6
14. Chirald(r), 99%
15. Chirald [mi]
16. Schembl924297
17. Zinc56565
18. Dtxsid70273961
19. Akos015894842
20. (s-(r*,s*))-alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenylphenethyl Alcohol
21. (2s,3r)-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol, (2s,3r)-(+)-4-dimethylamino-3-methyl-1,2-diphenyl-2-butanol, Dextrocarbinol Base
22. W-110904
23. Q27261634
24. Dextropropoxyphene Hydrochloride Impurity A [ep Impurity]
25. [s-(r*,s*)]-[2-(dimethylamino)-1-methylethyl]-phenylphenethyl Alcohol
26. Benzeneethanol, ?-[(1r)-2-(dimethylamino)-1-methylethyl]-?-phenyl-, (?s)-
| Molecular Weight | 283.4 g/mol |
|---|---|
| Molecular Formula | C19H25NO |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 283.193614421 g/mol |
| Monoisotopic Mass | 283.193614421 g/mol |
| Topological Polar Surface Area | 23.5 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 292 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Dextrocarbinol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dextrocarbinol, including repackagers and relabelers. The FDA regulates Dextrocarbinol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dextrocarbinol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dextrocarbinol supplier is an individual or a company that provides Dextrocarbinol active pharmaceutical ingredient (API) or Dextrocarbinol finished formulations upon request. The Dextrocarbinol suppliers may include Dextrocarbinol API manufacturers, exporters, distributors and traders.
click here to find a list of Dextrocarbinol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dextrocarbinol DMF (Drug Master File) is a document detailing the whole manufacturing process of Dextrocarbinol active pharmaceutical ingredient (API) in detail. Different forms of Dextrocarbinol DMFs exist exist since differing nations have different regulations, such as Dextrocarbinol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dextrocarbinol DMF submitted to regulatory agencies in the US is known as a USDMF. Dextrocarbinol USDMF includes data on Dextrocarbinol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dextrocarbinol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dextrocarbinol suppliers with USDMF on PharmaCompass.
Dextrocarbinol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dextrocarbinol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dextrocarbinol GMP manufacturer or Dextrocarbinol GMP API supplier for your needs.
A Dextrocarbinol CoA (Certificate of Analysis) is a formal document that attests to Dextrocarbinol's compliance with Dextrocarbinol specifications and serves as a tool for batch-level quality control.
Dextrocarbinol CoA mostly includes findings from lab analyses of a specific batch. For each Dextrocarbinol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dextrocarbinol may be tested according to a variety of international standards, such as European Pharmacopoeia (Dextrocarbinol EP), Dextrocarbinol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dextrocarbinol USP).
LOOKING FOR A SUPPLIER?
